Search

Journal: Current Drug Metabolism
Volume: 11 Issue: 8 Year: 2010 Page: 667-677
Author(s): V. Ancrenaz, Y. Daali, P. Fontana, M. Besson, C. Samer, P. Dayer, J. Desmeules

Clopidogrel High On-Treatment Platelet Reactivity in Patients with Carotid Artery Stenosis Undergoing Endarterectomy. A Pilot Study

Journal: Current Vascular Pharmacology
Volume: 14 Issue: 6 Year: 2016 Page: 563-569
Author(s): Dragana Backovic, Svetlana Ignjatovic, Ljiljana Rakicevic, Mirjana Novkovic, Jelena Kusic-Tisma, Dragica Radojkovic, Evgenija Strugarevic, Branko Calija, Djordje Radak, Mirjana Kovac

Progress of Antiplatelet Pharmacogenomics

Journal: Current Drug Targets
Volume: 12 Issue: 1 Year: 2011 Page: 1848-1858
Author(s): Julie H. Oestreich

CYP2D6 and CYP2C19 Genes Associated with Tricontinental and LatinAmerican Ancestry of Peruvians

Journal: Drug Metabolism and Bioanalysis Letters
Volume: 16 Issue: 1 Year: 2023 Page: 14-26
Author(s): Angel T. Alvarado,Roberto O. Ybañez-Julca,María R. Bendezú,Jorge A. García

Effects of CYP2C19 Polymorphism on Endothelial Function, Arterial Stiffness and Inflammation in Coronary Artery Disease Patients Under Clopidogrel Treatment

Journal: Current Pharmaceutical Design
Volume: 21 Issue: 34 Year: 2015 Page: 5041-5046
Author(s): Gerasimos Siasos,Marina Zaromitidou,Evangelos Oikonomou,Konstantinos Mourouzis,Sotiris Tsalamandris,Stamatios Kioufis,Eleni Kokkou,Manolis Vavuranakis,Theodoros Zografos,Alexis Antonopoulos,Stathis Dimitropoulos,Christodoulos Stefanadis,Athanasios G. Papavassiliou,Dimitris Tousoulis

Cytochrome P450 2C19 Polymorphism and Antiplatelet Therapy. Who Should Really be Genotyped?

Journal: Current Pharmaceutical Design
Volume: 19 Issue: 1 Year: 2013 Page: 2489-2495
Author(s): George Kassimis, Eleana F. Stavrou, Dimitrios Alexopoulos, Aglaia Athanassiadou

The Cytochrome P450 2C19 Polymorphism Associated with Major AdverseCardiovascular Events Risk in Kazak Patients Undergoing PercutaneousCoronary Intervention and Receiving Clopidogrel

Journal: Endocrine, Metabolic & Immune Disorders - Drug Targets
Volume: 23 Issue: 2 Year: 2023 Page: 196-204
Author(s):

Pharmacogenetic Testing for Clopidogrel: State of the ART

Journal: Current Pharmacogenomics and Personalized Medicine
Volume: 11 Issue: 3 Year: 2013 Page: 203-215
Author(s): Claudia Saracini,Silvia Galora,Anna Maria Palombella,Rosanna Abbate,Betti Giusti

The Role of the Cytochrome P450 Polymorphisms in Clopidogrel Efficacy and Clinical Utility

Journal: Current Medicinal Chemistry
Volume: 18 Issue: 3 Year: 2011 Page: 427-438
Author(s): D. Tousoulis, G. Siasos, M. Zaromytidou, N. Papageorgiou, E. Stefanadi, E. Oikonomou, C. Stefanadis

Genetic Variations in Cytochrome P450 2C9 and 2C19: A Review

Journal: Current Pharmacogenomics and Personalized Medicine
Volume: 14 Issue: 1 Year: 2016 Page: 18-28
Author(s): Abdoljalal Marjani